Owen Hughes

Provides investment services

Brookside Capital designs, implements, and manages customized portfolios of liquid assets for their clients. In selecting assets, the firm's decision-making process begins with consideration of long-term social, economic, and political themes. Portfolio investments may include domestic and foreign equities, fixed-income securities, mutual funds, exchange-traded funds, and limited partnerships, as well as cash equivalents.

Ziff Brothers Investments is an active investor, and manages portfolios invested in both publicly listed and private securities across asset classes, borders and a broad range of sectors, including energy, and high-technology.

Provides stock brokerage and asset management services

MLGP's objective is to generate long-term capital gains, with a primary focus on control-oriented investments in equity, equity-related and similar securities with equity-like returns. Investments typically range in size from $250 million to $750 million, with the flexibility to commit to larger or smaller investments. MLGP makes investments globally, with a primary emphasis on the world's largest economies, including the US, Europe, Japan, China, India, Latin America and Australia, taking a multi-sector approach to identifying attractive investment opportunities. They target investments in high quality, established companies that are recognized brands with industry or regional leadership, defensible market positions, strong cash flow characteristics and seasoned management. They combine comprehensive regional and industry-based in-depth analyses with global approval and management processes. Their approach combines an intensive, bottom-up evaluation process including gaining a detailed understanding of a potential portfolio company's value drivers, management capabilities, cost structure, cash flow characteristics, market position and competitive advantages with a top-down analysis of the attractiveness, growth potential and underlying economics of the industry, competitive environment and exit alternatives. When making an investment, MLGPE takes a control-oriented approach and seeks to structure transactions to ensure the ability to influence critical decisions for a portfolio company, particularly as it relates to specific value-added initiatives. A key element of their transaction negotiation with partners and management centers on contractual rights and board representation that facilitate input into key decisions such as management changes, expansion plans, acquisitions, budgets, debt and equity financings and new initiatives. MLGP implements value creation initiatives such as organic growth alternatives, acquisitions and other strategic initiatives, business rationalization and operational improvements and capital structure improvements in partnership with portfolio company management. They are actively involved in significant portfolio company decisions, including those relating to potential acquisitions, expansion plans, debt and equity financings, changes in senior management and new business initiatives.

Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system

FIAM utilizes a variety of methods of security analysis to select investments, including fundamental, quantitative, technical and macro-economic analysis in managing client accounts. The firm's global research resources include seasoned, sector-focused fundamental analysts covering industry sectors across the US and global markets as well as quantitative and technical portfolio managers and analysts.

Develops targeted protein degradation therapeutics for the treatment of cancer

Provides solutions to skin-related medical problems through proprietary biomaterials technologies

Develops small molecule therapeutics for multiple protein misfolding diseases

Develops metabolic enzymes based immunotherapy for oncology applications

Provides investment services for cancer treatments

Develops and commercializes genetic medicines

Operates as a biotechnology company that develops antibodies for the treatment of cancer

Develops and sells medicines to treat and cure solid tumors

Operates as a clinical-stage precision oncology company

Operates as a biopharmaceutical company

Operates as a blank check company